These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7636180

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Interaction of various cytokines with interleukin 2 in the generation of killer cells from human bone marrow: application in purging of leukemia.
    Charak BS, Agah R, Gray D, Mazumder A.
    Leuk Res; 1991; 15(9):801-10. PubMed ID: 1921458
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Effect of cytokines on NK cell activity and activating receptor expression in high-risk cutaneous melanoma patients.
    Martinović KM, Milićević M, Larsen AK, Džodić R, Jurišić V, Konjević G, Vuletić A.
    Eur Cytokine Netw; 2019 Dec 01; 30(4):160-167. PubMed ID: 32096478
    [Abstract] [Full Text] [Related]

  • 45. Comparative study of antiproliferative effects of chlorpromazine, 7,8-dioxochlorpromazine, amantadine-N-mustard, rutin-N-mustard and alpha, beta and gamma interferon on K-562 cells in vitro.
    Molnár J, Prágai B, Berencsi K, Mándi Y, Földeák S.
    Acta Microbiol Hung; 1985 Dec 01; 32(4):379-86. PubMed ID: 3939072
    [Abstract] [Full Text] [Related]

  • 46. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2.
    Malygin AM, Meri S, Timonen T.
    Scand J Immunol; 1993 Jan 01; 37(1):71-6. PubMed ID: 8380302
    [Abstract] [Full Text] [Related]

  • 47. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, Cook GP.
    PLoS One; 2011 Jan 01; 6(9):e22842. PubMed ID: 21909397
    [Abstract] [Full Text] [Related]

  • 48. Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10.
    Cui C, Feng H, Shi X, Wang Y, Feng Z, Liu J, Han Z, Fu J, Fu Z, Tong H.
    Int Immunopharmacol; 2015 Jul 01; 27(1):110-21. PubMed ID: 25978851
    [Abstract] [Full Text] [Related]

  • 49. Inhibitory effects of transforming growth factor-beta (TGF-beta) on certain functions of intraepithelial lymphocytes.
    Ebert EC.
    Clin Exp Immunol; 1999 Mar 01; 115(3):415-20. PubMed ID: 10193412
    [Abstract] [Full Text] [Related]

  • 50. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.
    Kuppner MC, Hamou MF, Sawamura Y, Bodmer S, de Tribolet N.
    J Neurosurg; 1989 Aug 01; 71(2):211-7. PubMed ID: 2545842
    [Abstract] [Full Text] [Related]

  • 51. Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-beta.
    Ishizaka S, Kimoto M, Kanda S, Saito S.
    Immunology; 1998 Nov 01; 95(3):460-5. PubMed ID: 9824511
    [Abstract] [Full Text] [Related]

  • 52. Transforming Growth Factor-β and Tumor Necrosis Factor-α Reduce the Sensitivity of MiaPaCa2 Pancreatic Cancer Cells to Lysis by NK Cells.
    Ostapchuk EO, Kali A, Belyaev NN.
    Bull Exp Biol Med; 2018 Jun 01; 165(2):259-263. PubMed ID: 29926278
    [Abstract] [Full Text] [Related]

  • 53. Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2.
    Nair MP, Schwartz SA.
    Clin Diagn Lab Immunol; 2000 Jan 01; 7(1):101-5. PubMed ID: 10618286
    [Abstract] [Full Text] [Related]

  • 54. Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells.
    Shokri MR, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, Shokri F, Zarnani AH.
    Sci Rep; 2019 Jul 10; 9(1):10007. PubMed ID: 31292483
    [Abstract] [Full Text] [Related]

  • 55. Peripheral blood NK cells expressing HLA-G, IL-10 and TGF-β in healthy donors and breast cancer patients.
    Ostapchuk YO, Cetin EA, Perfilyeva YV, Yilmaz A, Skiba YA, Chirkin AP, Omarbaeva NA, Talaeva SG, Belyaev NN, Deniz G.
    Cell Immunol; 2015 Jul 10; 298(1-2):37-46. PubMed ID: 26362675
    [Abstract] [Full Text] [Related]

  • 56. Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitro.
    Schröder CP, Maurer HR.
    Cancer Immunol Immunother; 2001 Apr 10; 50(2):69-76. PubMed ID: 11401027
    [Abstract] [Full Text] [Related]

  • 57. Immunoregulatory effects of transforming growth factor-beta in a prolonged period of culture.
    Ishizaka S, Yoshikawa M, Tsujii T.
    Cell Immunol; 1992 Jan 10; 139(1):239-47. PubMed ID: 1728967
    [Abstract] [Full Text] [Related]

  • 58. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.
    Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA.
    J Exp Med; 1990 Dec 01; 172(6):1777-84. PubMed ID: 2258706
    [Abstract] [Full Text] [Related]

  • 59. Modulation of the immunostimulating effect of autologous tumor vaccine by anti-TGF-beta antibody and interferon-alpha on murine MBT-2 bladder cancer.
    Tzai TS, Shiau AL, Lin CS, Wu CL, Lin JS.
    Anticancer Res; 1997 Dec 01; 17(2A):1073-8. PubMed ID: 9137451
    [Abstract] [Full Text] [Related]

  • 60. Immunomodulatory properties of diazepam-binding inhibitor: effect on human interleukin-6 secretion, lymphocyte proliferation and natural killer cell activity in vitro.
    Stepień H, Agro A, Crossley J, Padol I, Richards C, Stanisz A.
    Neuropeptides; 1993 Sep 01; 25(3):207-11. PubMed ID: 8247258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.